Vigil Neuroscience, Inc. (VIGL)

NASDAQ: VIGL · IEX Real-Time Price · USD

2.710

+0.130 (5.04%)

At close: Apr 26, 2024, 4:00 PM

2.830

+0.120 (4.43%)

After-hours: Apr 26, 2024, 6:56 PM EDT

Vigil Neuroscience Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021
Cash & Equivalents	52.92	187.53	92.35
Short-Term Investments	65.95	0	0
Cash & Cash Equivalents	118.87	187.53	92.35
Cash Growth	-36.62%	103.07%	-
Other Current Assets	3.04	10.27	5.14
Total Current Assets	121.91	197.81	97.48
Property, Plant & Equipment	17.94	1.4	1.27
Other Long-Term Assets	1.01	1.19	3.68
Total Long-Term Assets	18.95	2.59	4.96
Total Assets	140.86	200.39	102.44
Accounts Payable	1.95	1.94	3.98
Current Debt	0.91	0.18	0.87
Other Current Liabilities	8.81	9.19	5.03
Total Current Liabilities	11.66	11.31	9.88
Long-Term Debt	12.95	0	0.06
Total Long-Term Liabilities	12.95	0	0.06
Total Liabilities	24.61	11.31	9.95
Total Debt	13.85	0.18	0.94
Debt Growth	7769.32%	-81.22%	-
Retained Earnings	-222.77	-140.13	-71.83
Comprehensive Income	-0.01	0	0
Shareholders' Equity	116.25	189.08	-69.44
Net Cash / Debt	105.02	187.36	91.41
Net Cash / Debt Growth	-43.95%	104.96%	-
Net Cash Per Share	2.71	5.91	59.68
Working Capital	110.25	186.49	87.6
Book Value Per Share	3.00	5.97	-45.34

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).